Your browser doesn't support javascript.
loading
Elevated levels of peritumoral chondroitin sulfate are predictive of poor prognosis in patients treated by radical prostatectomy for early-stage prostate cancer.
Ricciardelli, C; Quinn, D I; Raymond, W A; McCaul, K; Sutherland, P D; Stricker, P D; Grygiel, J J; Sutherland, R L; Marshall, V R; Tilley, W D; Horsfall, D J.
Afiliação
  • Ricciardelli C; Oncology Unit, Flinders Cancer Centre, Flinders University and Flinders Medical Centre, Adelaide, South Australia, Australia.
Cancer Res ; 59(10): 2324-8, 1999 May 15.
Article em En | MEDLINE | ID: mdl-10344737
Buscar no Google
Base de dados: MEDLINE Assunto principal: Prostatectomia / Neoplasias da Próstata / Adenocarcinoma / Biomarcadores Tumorais / Sulfatos de Condroitina Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Humans / Male / Middle aged Idioma: En Ano de publicação: 1999 Tipo de documento: Article
Buscar no Google
Base de dados: MEDLINE Assunto principal: Prostatectomia / Neoplasias da Próstata / Adenocarcinoma / Biomarcadores Tumorais / Sulfatos de Condroitina Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Humans / Male / Middle aged Idioma: En Ano de publicação: 1999 Tipo de documento: Article